Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study

Tapentadol (TAP) and oxycodone/naloxone (OXN) potentially offer an improved opioid tolerability. However, real-world studies in chronic non-cancer pain (CNCP) remain scarce. Our aim was to compare effectiveness and security in daily pain practice, together with the influence of pharmacogenetic marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Barrachina, Jordi, Margarit, Cesar, Muriel, Javier, López-Gil, Santiago, López-Gil, Vicente, Vara-González, Amaya, Planelles, Beatriz, Inda, María-del-Mar, Morales, Domingo, Peiró, Ana M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203709/
https://www.ncbi.nlm.nih.gov/pubmed/35710811
http://dx.doi.org/10.1038/s41598-022-13085-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203709/
https://www.ncbi.nlm.nih.gov/pubmed/35710811
http://dx.doi.org/10.1038/s41598-022-13085-5

Ejemplares similares